clinical trial management
CROs
Patient recruitment
Decodeon
major bottleneck
big pharma tenders clinical trials
drug development time
efficient patient registries
major inefficiency
major node
associated costs
successful execution of rare disease drug trials
rare disease patients
faster development of treatments forRare Diseases Patient availability
pharma companies
uniQue platform
specific inclusion
novel platform
total costs
letters of support
required numbers
Contract Research Organisations
key elements
value chain
exclusion criteria
Phase
unexplored market worth
consequence
CRO efficiency
lump sum
failure
proposal
duration